Mike Ouimette - Dec 19, 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Signature
/s/ Mike Ouimette
Stock symbol
PLRX
Transactions as of
Dec 19, 2022
Transactions value $
-$90,144
Form type
4
Date filed
12/21/2022, 08:32 PM
Previous filing
Feb 2, 2022
Next filing
Dec 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Award $0 +13.6K $0.00 13.6K Dec 19, 2022 Direct F1
transaction PLRX Common Stock Sale -$90.1K -4.72K -34.71% $19.10 8.88K Dec 20, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 28, 2022, the Reporting Person was granted 54,375 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On December 19, 2022, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 13,594 shares.
F2 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker at prices ranging from $18.4049 to $19.64, inclusive, on December 20, 2022 and December 21, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee in connection with the vesting of previously granted performance-vested stock units. The Reporting Person undertakes to provide to Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (2) to this Form 4.